Abstract:Lung cancer has emerged as a leading cause of cancer death in the world. Non-small cell lung cancer (NSCLC) accounts for 75–80% of all lung cancers. Current therapies are ineffective, thus new approaches are needed to improve the therapeutic ratio. Double stranded RNA (dsRNA) -mediated RNA interference (RNAi) has shown promise in gene silencing, the potential of which in developing new methods for the therapy of NSCLC needs to be tested. We report here RNAi induced effective silencing of the epidermal growth factor receptor (EGFR) gene, which is over expressed in NSCLC. NSCLC cell lines A549 and SPC-A1 were transfected with sequence- specific dsRNA as well as various controls. Immune fluorescent labeling and flow cytometry were used to monitor the reduction in the production of EGFR protein. Quantitative reverse-transcriptase PCR was used to detect the level of EGFR mRNA. Cell count, colony assay, scratch assay, MTT assay in vitro and tumor growth assay in athymic nude mice in vivo were used to assess the functional effects of EGFR silencing on tumor cell growth and proliferation. Our data showed transfection of NSCLC cells with dsRNA resulted in sequence specific silencing of EGFR with 71.31% and 71.78 % decreases in EGFR protein production and 37.04% and 54.92% in mRNA transcription in A549 and SPC-A1 cells respectively. The decrease in EGFR protein production caused significant growth inhibition, i.e.: reducing the total cell numbers by 85.0% and 78.3 %, and colony forming numbers by 63.3% and 66.8%. These effects greatly retarded the migration of NSCLC cells by more than 80% both at 24 h and at 48 h, and enhanced chemo-sensitivity to cisplatin by four-fold in A549 cells and seven-fold in SPC-A1. Furthermore, dsRNA specific for EGFR inhibited tumor growth in vivo both in size by 75.06 % and in weight by 73.08 %. Our data demonstrate a new therapeutic effect of sequence specific suppression of EGFR gene expression by RNAi, enabling inhibition of tumor proliferation and growth. However, in vivo use of dsRNA for gene transfer to tumor cells would be limited because dsRNA would be quickly degraded once delivered in vivo. We thus tested a new bovine lentiviral vector and showed lentivector-mediated RNAi effects were efficient and specific. Combining RNAi with this gene delivery system may enable us to develop RNAi for silencing EGFR into an effective therapy for NSCLC.

[Effects of RNA Interference on Epidermal Growth Factor Receptor Expression in SPC-A-1 Cells].

Inhibition of Epidermal Growth Factor Receptor Expression by RNA Interference in A549 Cells

[Antitumor Effect of Epidermal Growth Factor Receptor Gene Silencing].

[Effect of RAD18-siRNA on Proliferation and Chemotherapy Sensitivity of Human Esophageal Squamous Cell Carcinoma ECA-109 Cells].

Antitumor effect of RNA interference on non-small cell lung cancer in vivo

RNA Interference for Epidermal Growth Factor Receptor Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell Line Eca109

RNA interference mediated inhibition of epidermal growth factor receptor expression and its significance in different human cancer cell lines

Silencing the Epidermal Growth Factor Receptor Gene with RNAi May Be Developed As a Potential Therapy for Non Small Cell Lung Cancer.

Construction of Small Interfering RNA Expression Vector Targeting EGFR Gene and Its Biologic Effects

[Effect of siRNA for mutant p53 gene on biological behavior of gastric cancer cell line SGC7901].

Antitumor Effect of RNA Interference on Non-Small-cell Lung Cancer in Vivo

Transient Transfection of Short Hairpin RNA Targeting Epidermal Growth Factor Receptor into Lung Adenocarcinoma A549 Cell Line and Its Effect on Cell Growth and Sensitivity to Cytotoxic Drugs

Potential Role of Short Hairpin RNA Targeting Epidermal Growth Factor Receptor in Growth and Sensitivity to Drugs of Human Lung Adenocarcinoma Cells.

Experimental study of antisense epidermal growth factor receptor enhancing the radiosensitivity of human lung cancer cell line spc-a-1

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Suppression of Insulin-Like Growth Factor-1 Receptor by RNA Interference Inhibits Cell Growth in Vitro and Induces Chemosensitization of HO8910PM Cell to Cisplatin

A Linear Polyethylenimine Mediated Sirna-Based Therapy Targeting Human Epidermal Growth Factor Receptor in SPC-A1 Xenograft Mice.

Antitumor Efficacy of SLPI Promoter-Controlled Expression of Artificial microRNA Targeting EGFR in a Squamous Cell Carcinoma Cell Line

Biological Behaviors and Chemosensitivity of NSCLC A549 Cells after IGF-I R Gene Silencing by Targeting RNAi in Vitro

Small Interfering RNA Inhibits Cell Proliferation in Gastric Cancer Cell Lines Highly Expressing RegIα

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.